Reuters logo
BRIEF-Erytech Pharma announces trading suspension of its ordinary shares on Euronext paris​
November 10, 2017 / 8:48 AM / 9 days ago

BRIEF-Erytech Pharma announces trading suspension of its ordinary shares on Euronext paris​

Nov 10 (Reuters) - ERYTECH PHARMA SA:

* ERYTECH ANNOUNCES TRADING SUSPENSION OF ITS ORDINARY SHARES ON EURONEXT PARIS

* SUSPENSION TO ALLOW FOR CONFIRMATION OF ALLOCATIONS TO INVESTORS & CO‘S ADSS BEGINNING TRADING ON NASDAQ GLOBAL SELECT MARKET

* ‍SUSPENSION EFFECTIVE UNTIL A NEW COMMUNICATION IS RELEASED BY COMPANY​

* ‍TRADING ON REGULATED MARKET OF EURONEXT PARIS EXPECTED TO RESUME NOV 10, 2017 ABOUT 4:00 PM (CET)​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below